AMO pull out of B&L bid

Article

Advanced Medical Optics (AMO) has withdrawn its bid to buy Bausch & Lomb (B&L), according to a letter issued to B&L by AMO president, James V. Mazzo. The decision was made after B&L refused to grant more time to AMO to prove that it could gain the support needed from shareholders.

Advanced Medical Optics (AMO) has withdrawn its bid to buy Bausch & Lomb (B&L), according to a letter issued to B&L by AMO president, James V. Mazzo. The decision was made after B&L refused to grant more time to AMO to prove that it could gain the support needed from shareholders.

B&L had been trying to decide between AMO's cash and stock offer and a $65 per share all-cash offer made by the private equity firm Warburg Pincus in May. B&L initially accepted the latter but was allowed to solicit better offers during a 50-day "go shop" period. AMO made its offer on 5th July, the last day of the go-shop period.

On 24th July, B&L told AMO that it preferred Warburg Pincus' offer and gave the company until 3rd August to provide concrete, credible evidence of shareholder approval. AMO responded that it needed several weeks to convince its shareholders of the deal's potential value, however, this extension was not granted by B&L, hence AMO's decision to withdraw.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.